Latest News
13-Jan-2026 HC Allows Zydus to Market Cancer Biosimilar Drug
09-Jan-2026 Cardiac Drugs Log Highest Sales as NCD Cases Surge
08-Jan-2026 GLP-1 May become a Sure Shot Choice for Diabetes Care
05-Jan-2026 HC Seeks Govt Reply on Plea Against Online Diagnostic Services
01-Jan-2026 Ministry in Talks with States to Give Some Drug Cos More Time for GMP Compliance
  more...
Latest Reports
Jan-26 Pharma Weekender– In case you missed it - Emkay Research  
Jan-26 Q3FY26–Seasonality to hit hospitals - Emkay Research  
Jan-26 Base business momentum to offset gRevlimid drag - HDFC Securities  
Jan-26 Indian CRDMOs at a pivotal point; scale-up key - HDFC Securities  
Jan-26 Growth sustains despite seasonal lull - Nuvama  
  more...

Quarterly Summary September-2025
Desc Current Previous Per.Chg
Sales 69704.5 69535.4 0.2
Otherincome 3582.4 2652.8 35.0
Expense 54109.9 51586.9 4.9
RawMaterial 20222.3 19756.9 2.4
StaffCost 11464.9 10460.1 9.6
ExciseDuty 17.0 8.8 93.2
OtherExp 16066.7 15807.9 1.6
Interest 1339.9 1160.6 15.5
GrossProfit 19362.6 20742.2 -6.7
Depreciation 3085.3 2813.3 9.7
Tax 3536.7 4195.0 -15.7
NetProfit 12267.1 13807.6 -11.2
Total.Comp 189 -- --
Source: ETIG Database

Sectoral Companies As on 13 Jan 2026
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 415030.91
Divi's Lab 170782.57
Torrent Phar 133330.13
Cipla 116929.89
Lupin 99436.22
Dr.Reddy's 99346.61
Mankind Phar 91354.70
Zydus Life 90583.16
Alkem Labora 70055.70
Aurobindo Ph 68377.46
Abbott (I) 59688.59
Laurus Labs 57072.94
Biocon 56905.90
  click here for the complete list